A systematic review of the applications of Mendelian randomization assessing the causal relevance of the gut microbiome in human health and disease | 10.1101/2025.06.03.25328787 | 2025-06-03 |
New insights into understanding obesity | 10.1136/bmjmed-2023-000787 | 2024-03-29 |
Inflammation proteomics datasets in the ALSPAC cohort | 10.12688/wellcomeopenres.18482.2 | 2024-02-19 |
Impact of weight loss on cancer-related proteins in serum: results from a cluster randomised controlled trial of individuals with type 2 diabetes | 10.1016/j.ebiom.2024.104977 | 2024-02 |
The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT) | 10.1007/s00125-023-06019-x | 2024-01-01 |
Using trials of caloric restriction and bariatric surgery to explore the effects of body mass index on the circulating proteome | 10.1038/s41598-023-47030-x | 2023-11-29 |
Prevalence of Deleterious Variants in MC3R in Patients With Constitutional Delay of Growth and Puberty | 10.1210/clinem/dgad373 | 2023-11-17 |
Characterizing the Effect of Adiposity on Cardiometabolic Traits and the Circulating Proteome in Qatar Biobank | No DOI available. | 2023-09-17 |
Loci for insulin processing and secretion provide insight into type 2 diabetes risk | 10.1016/j.ajhg.2023.01.002 | 2023-02-02 |
Characterising the circulating proteome of adiposity through use of weight loss interventions and Mendelian randomisation | No DOI available. | 2022-10-28 |
Higher body mass index raises immature platelet count: potential contribution to obesity-related thrombosis | 10.1080/09537104.2021.2003317 | 2022-08-18 |
The metabolomic signature of weight loss in the Diabetes Remission Clinical Trial (DiRECT) | 10.1101/2022.07.15.22277671 | 2022-07-17 |
A multivariant recall‐by‐genotype study of the metabolomic signature of BMI | 10.1002/oby.23441 | 2022-06 |
Long-term metabolomic effects of bariatric surgery | No DOI available. | 2022-06 |
metaboprep: an R package for preanalysis data description and processing | 10.1093/bioinformatics/btac059 | 2022-03-28 |
Epigenetic Regulation of F2RL3 Associates With Myocardial Infarction and Platelet Function | 10.1161/CIRCRESAHA.121.318836 | 2022-02-04 |
Evaluating the association of TRPA1 gene polymorphisms with pain sensitivity | 10.1186/s12920-022-01156-5 | 2022-01-12 |
A multivariant recall-by-genotype study of the metabolomic signature of BMI (vol 30, pg 1298, 2022) | 10.1002/OBY.23541 | 2022 |
Using non-linear and stratified Mendelian randomisation to explore relationships between body mass index and the plasma proteome | No DOI available. | 2022 |
Schizophrenia-associated variation at ZNF804A correlates with altered experience-dependent dynamics of sleep slow waves and spindles in healthy young adults | 10.1093/sleep/zsab191 | 2021-12-10 |
Investigation of the Interplay between Circulating Lipids and IGF-I and Relevance to Breast Cancer Risk: An Observational and Mendelian Randomization Study | 10.1158/1055-9965.EPI-21-0315 | 2021-12-01 |
Effects of adiposity on the human plasma proteome: observational and Mendelian randomisation estimates | 10.1038/s41366-021-00896-1 | 2021-10-05 |
The blood metabolome of incident kidney cancer: A case–control study nested within the MetKid consortium | 10.1371/journal.pmed.1003786 | 2021-09-20 |
metaboprep: an R package for pre-analysis data description and processing | 10.1101/2021.07.07.451488 | 2021-07-09 |
The trans-ancestral genomic architecture of glycemic traits | 10.1038/s41588-021-00852-9 | 2021-06-31 |
Loss-of-function mutations in the melanocortin 4 receptor in a UK birth cohort | 10.1038/s41591-021-01349-y | 2021-06 |
Correction to: Metabolic characterisation of disturbances in the APOC3/triglyceride‑rich lipoprotein pathway through sample‑based recall by genotype | 10.1007/s11306-020-01765-0 | 2021-02 |
The Role of Inflammatory Cytokines as Intermediates in the Pathway from Increased Adiposity to Disease | 10.1002/oby.23060 | 2021-02 |
A multi-variant recall-by-genotype study of the metabolomic signature of body mass index | 10.1101/2021.10.21.465319 | 2021 |
Combining Mendelian Randomization and Randomized Control Trial Study Designs to Determine Effects of Adiposity on the Plasma Proteome | No DOI available. | 2021 |
Combining Mendelian Randomization and Randomized Control Trial Study Designs to Determine Effects of Adiposity on the Plasma Proteome | No DOI available. | 2021 |
Effects of adiposity on the human plasma proteome: Observational and Mendelian randomization estimates | 10.1101/2020.06.01.20119081 | 2021 |
Prevalence and expressivity of loss of function mutations in the Melanocortin 4 Receptor (MC4R) in a UK birth cohort | 10.1101/2020.10.30.20220467 | 2020-11-03 |
Metabolic characterisation of disturbances in the APOC3/triglyceride-rich lipoprotein pathway through sample-based recall by genotype | 10.1007/s11306-020-01689-9 | 2020-06 |
An independent locus upstream of ASIP controls variation in the shade of the bay coat colour in horses | 10.3390/genes11060606 | 2020-05-30 |
Common variation at 16p11.2 is associated with glycosuria in pregnancy: Findings from a genome-wide association study in European women. | 10.1093/hmg/ddaa054 | 2020-03-30 |
Genetic architecture of human thinness compared to severe obesity | 10.1371/journal.pgen.1007603 | 2019-01-24 |
Apparent latent structure within the UK Biobank sample has implications for epidemiological analysis | 10.1038/s41467-018-08219-1 | 2019-01-18 |
Epigenetic regulation of PAR4-related platelet activation: mechanistic links between environmental exposure and cardiovascular disease | 10.1101/473728 | 2018-11-22 |
Formalising recall by genotype as an efficient approach to detailed phenotyping and causal inference | 10.1038/s41467-018-03109-y | 2018-02-19 |
Investigating the role of insulin in increased adiposity: Bi-directional Mendelian randomization study | No DOI available. | 2017-06-28 |
A reference panel of 64,976 haplotypes for genotype imputation. | 10.1038/ng.3643 | 2016-10 |
BMI as a Modifiable Risk Factor for Type 2 Diabetes: Refining and Understanding Causal Estimates Using Mendelian Randomization. | 10.2337/db16-0418 | 2016-10 |
Body mass index: Has epidemiology started to break down causal contributions to health and disease? | 10.1002/oby.21554 | 2016-08 |
Genetics, sleep and memory: a recall-by-genotype study of ZNF804A variants and sleep neurophysiology. | 10.1186/s12881-015-0244-4 | 2015-10 |
Using inactivating mutations to provide insight into drug action. | 10.1186/s13073-015-0130-x | 2015 |
The utility of low-density genotyping for imputation in the Thoroughbred horse. | 10.1186/1297-9686-46-9 | 2014-02 |
Mis-matches between adiposity and glycaemic traits: A replicated genome-wide association study for metabolic disparity | No DOI available. | 2014 |
Advances in equine genomics | No DOI available. | 2013-04 |
The application of genomic technologies to the horse | No DOI available. | 2013 |
A participatory approach to understanding the issues associated with establishing an equine biobank | No DOI available. | 2012-11-17 |
Coalescence theory in livestock breeding. | 10.1111/j.1439-0388.2012.01016.x | 2012-08 |
Estimation of historical effective population size using linkage disequilibria with marker data. | 10.1111/j.1439-0388.2012.01003.x | 2012-08 |
The identification of SNPs with indeterminate positions using the Equine SNP50 BeadChip. | 10.1111/j.1365-2052.2011.02243.x | 2012-06 |
A genome-wide association study of osteochondritis dissecans in the Thoroughbred. | 10.1007/s00335-011-9363-1 | 2012-04 |
Linkage disequilibrium and historical effective population size in the Thoroughbred horse. | 10.1111/j.1365-2052.2010.02092.x | 2010-12 |
Genomic prediction of risk for osteochondrosis in the Thoroughbred horse. | No DOI available. | 2010-01 |
Characterisation of linkage disequilibrium and subsequent estimation of effective population size in Thoroughbred horses using SNP markers | No DOI available. | 2010 |
The impact of method on the estimated effective population size of a Thoroughbred population using genotype data | No DOI available. | 2010 |